Skip to main content
. 2022 Apr 21;45(7):zsac088. doi: 10.1093/sleep/zsac088

Figure 3.

Figure 3.

Risk of CKD progression for the participants with no/mild OSA and no insomnia (A: NM-OSA, n = 199), insomnia with short sleep duration (B: Insomnia-SD, n = 100), moderate-to-severe OSA and no insomnia (C: MS-OSA, n = 225), and COMISA with short sleep duration (D: COMISA-SD, n = 166) after exclusion of 42 participants at moderate-to-very high risk of CKD progression with a history of reduced kidney function and/or proteinuria. Colored boxes indicate the number (% of group) with low (green), moderate (yellow), high (orange), and very high (red) risk of CKD progression. Blue line surrounds the 11.1% of NM-OSA, 12% of Insomnia-SD, 21.3% of MS-OSA, and 24.7% of COMISA-SD participants who are at moderate-to-very high risk of kidney disease progression.